Bryan Irving Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Bryan Irving.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Bryan Irving. Bryan Irving is a EVP, Chief Scientific Officer in FIVE PRIME THERAPEUTICS INC ($FPRX) and a SVP, Research in FIVE PRIME THERAPEUTICS INC ($FPRX).

Address: TWO CORPORATE DRIVE SOUTH SAN FRANCISCO 94080 CA

Companies in which Bryan Irving is an Insider

FIVE PRIME THERAPEUTICS, INC.

Trading Symbol: FPRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bryan Irving: EVP, Chief Scientific Officer, SVP, Research
Holdings: 30,533 shares
Current Value: $1,385,588
Latest Transaction: May 16 2019
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Bryan Irving

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 16 2019FPRXFIVE PRIME THERAPE ...Irving BryanEVP, Chief Scientif ...Payment of ExerciseF9.176205,68530,53331.2 K to 30.5 K (-1.99 %)
Feb 27 2019FPRXFIVE PRIME THERAPE ...Irving BryanEVP, Chief Scientif ...Option ExerciseA11.9758,000694,26058,000
Feb 27 2019FPRXFIVE PRIME THERAPE ...Irving BryanEVP, Chief Scientif ...Payment of ExerciseF11.951,11813,36031,15332.3 K to 31.2 K (-3.46 %)
Feb 27 2019FPRXFIVE PRIME THERAPE ...Irving BryanEVP, Chief Scientif ...GrantA0.0010,000032,27122.3 K to 32.3 K (+44.90 %)
Sep 05 2018FPRXFIVE PRIME THERAPE ...Irving BryanEVP, Chief Scientif ...Payment of ExerciseF14.002,47934,70622,27124.8 K to 22.3 K (-10.02 %)
May 14 2018FPRXFIVE PRIME THERAPE ...Irving BryanEVP, Chief Scientif ...Option ExerciseA17.2722,500388,57522,500
May 14 2018FPRXFIVE PRIME THERAPE ...Irving BryanEVP, Chief Scientif ...GrantA0.003,750024,75021 K to 24.8 K (+17.86 %)

View all Bryan Irving insider transactions.